14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 CNTA stock ended at $9.25. This is 2.32% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 2.81% from a day low at $9.24 to a day high of $9.50.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Centessa Pharmaceuticals Limited prices

Date Open High Low Close Volume
Nov 03, 2023 $7.06 $7.50 $6.63 $7.35 499 142
Nov 02, 2023 $6.81 $7.37 $6.64 $6.85 118 831
Nov 01, 2023 $6.45 $7.12 $6.41 $6.85 300 977
Oct 31, 2023 $6.50 $6.80 $6.20 $6.57 81 614
Oct 30, 2023 $6.18 $6.91 $6.18 $6.60 368 866
Oct 27, 2023 $6.77 $7.08 $5.99 $6.15 111 917
Oct 26, 2023 $7.06 $7.45 $6.33 $6.79 178 615
Oct 25, 2023 $6.84 $6.85 $6.06 $6.24 556 134
Oct 24, 2023 $6.47 $6.93 $6.19 $6.64 26 084
Oct 23, 2023 $6.71 $7.08 $6.26 $6.49 75 360
Oct 20, 2023 $6.58 $7.04 $6.00 $6.83 27 031
Oct 19, 2023 $6.96 $7.01 $6.51 $6.77 47 584
Oct 18, 2023 $6.48 $7.23 $6.21 $7.01 179 796
Oct 17, 2023 $6.23 $6.97 $6.12 $6.78 266 866
Oct 16, 2023 $5.66 $6.40 $5.66 $6.34 33 230
Oct 13, 2023 $6.25 $6.43 $5.94 $6.01 22 506
Oct 12, 2023 $6.09 $6.31 $5.83 $6.14 31 723
Oct 11, 2023 $6.24 $6.31 $6.03 $6.07 18 203
Oct 10, 2023 $6.15 $6.50 $5.94 $6.25 26 832
Oct 09, 2023 $5.98 $6.33 $5.74 $6.28 28 539
Oct 06, 2023 $5.65 $6.14 $5.33 $6.01 184 859
Oct 05, 2023 $5.98 $6.10 $5.49 $5.84 237 997
Oct 04, 2023 $5.54 $6.15 $5.40 $5.88 73 411
Oct 03, 2023 $5.69 $5.80 $5.15 $5.52 125 892
Oct 02, 2023 $6.40 $6.40 $5.23 $5.62 217 909
Click to get the best stock tips daily for free!

About Centessa Pharmaceuticals Limited

Centessa Pharmaceuticals Limited Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; and SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatm... CNTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT